Masakazu Toi

45PUBLICATIONS
205CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Biomedical imagingCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|May 19, 2026
Exploratory analysis of PTEN deficiency by immunohistochemistry from the Phase III CAPItello-291 trial.

|Apr 16, 2026
Dynamic changes in serum HER2-peptide-specific autoantibodies predict response to neoadjuvant therapy in HER2-positive breast cancer.

|Apr 02, 2026
Response to the comment on "Locoregional indicators of systemic spread in breast cancer: insights from standard-of-care imaging and ¹⁸F-FDG PET/CT".

Yurika Kitano, Kanae K Miyake, Tomomi W Nobashi

|Mar 19, 2026
Long-term outcomes of eribulin‑based neoadjuvant chemotherapy for triple‑negative breast cancer patients stratified by homologous recombination deficiency status: results of the randomized JBCRG-22 study.

Norikazu Masuda, Hiroyuki Yasojima, Hiroko Bando

|Mar 13, 2026
Correction: Locoregional indicators of systemic spread in breast cancer: insights from standard-of-care imaging and ¹⁸F-FDG PET/CT.

Yurika Kitano, Kanae K Miyake, Tomomi W Nobashi

|Mar 13, 2026
Correction: Subcutaneous/cutaneous uptake in the cancer-affected breast on 18F-FDG PET/CT: association with post-surgical prognosis in breast cancer patients.

Yurika Kitano, Kanae K Miyake, Tomomi W Nobashi

Pageof 8

Frequent Collaborators

11 joint publications

Norikazu Masuda

8 joint publications

Masako Kataoka

7 joint publications

Kanae Kawai Miyake

6 joint publications

Takayoshi Ishimori